Physician profile
Deborah Friedlander
NPI 1689674574
$450.67
in general payments reported to CMS, 2019-2025
10 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.47 · 2023: $19.16 · 2024: $197 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $129.00 | 2025 | Airsupra |
| Pfizer INC. | $113.00 | 2019-2024 | |
| Abbott Laboratories | $68.76 | 2024-2025 | Navitor |
| Amgen INC. | $29.41 | 2025 | Repatha, Otezla |
| Lilly USA, LLC | $23.62 | 2025 | Mounjaro |
| Esperion Therapeutics, INC. | $20.09 | 2024 | Nexletol |
| Boston Scientific Corporation | $19.16 | 2023 | Bodyguardian |
| Novo Nordisk INC | $17.96 | 2024 | Ozempic |
| Janssen Pharmaceuticals, INC | $17.66 | 2024 | Xarelto |
| Glaxosmithkline, LLC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Friedlander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.